TVGN insider transaction filings
Tevogen Bio Holdings Inc. — 20 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-10. Screen TVGN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | Sordillo Victor J. — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-07-10 | 4 | Saadi Ryan H. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 1,220,000 @ $0 | EDGAR |
| 2026-07-10 | 4 | Patton Curtis L. — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-07-10 | 4 | Goh Keow Lin — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-07-10 | 4 | Feike Jeffrey L. — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-07-10 | 4 | Desai Kirti — Chief Financial Officer | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-07-10 | 4 | PODLOGAR SUSAN M — Director | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2026-03-17 | 4 | Flomenberg Neal — See Remarks | Sale (S): 19 @ $7.75 · Sale (S): 452 @ $7.26 · Sale (S): 501 @ $6.40 | EDGAR |
| 2025-12-22 | 4 | Saadi Ryan H. — Chief Executive Officer, Director, 10% owner | Gift (G): 50,000 @ $0 | EDGAR |
| 2025-12-15 | 4 | Desai Kirti — Chief Financial Officer | Gift (G): 300,000 @ $0 | EDGAR |
| 2025-12-12 | 4 | Saadi Ryan H. — Chief Executive Officer, Director, 10% owner | Gift (G): 460,000 @ $0 | EDGAR |
| 2025-08-18 | 4 | Saadi Ryan H. — Chief Executive Officer, Director, 10% owner | Gift (G): 20,000 @ $0 | EDGAR |
| 2025-07-01 | 4 | Saadi Ryan H. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 8,000,000 @ $0 | EDGAR |
| 2025-07-01 | 4 | Khan Sadiq — Chief Commercial Officer | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2025-07-01 | 4 | Flomenberg Neal — See Remarks | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-07-01 | 4 | Desai Kirti — Chief Financial Officer | Grant/award (A): 750,000 @ $0 | EDGAR |
| 2025-06-09 | 4 | Saadi Ryan H. — Chief Executive Officer, Director, 10% owner | Sale (S): 1,438,206 @ $1.23 | EDGAR |
| 2025-03-14 | 4 | Flomenberg Neal — See Remarks | Sale (S): 232,968 @ $1.09 | EDGAR |
| 2025-03-11 | 4 | Flomenberg Neal — See Remarks | Sale (S): 71,273 @ $1.14 · Sale (S): 70,384 @ $1.09 · Sale (S): 70,252 @ $1.05 | EDGAR |
| 2025-03-06 | 4 | Flomenberg Neal — See Remarks | Sale (S): 14,639 @ $1.28 · Sale (S): 110,659 @ $1.21 · Sale (S): 88,519 @ $1.10 | EDGAR |
Recent 8-K events — Tevogen Bio Holdings Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-03-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-04 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-07-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-07-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-30 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TVGN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →